Tel Aviv-based developer of AI-driven diagnostic systems that speed up and sharpen blood analysis for clinicians.
Founded in 2011 in Tel Aviv, Israel, S.D. Sight Diagnostics Ltd. develops AI-driven diagnostic systems for blood analysis, including infectious disease detection. Its systems are sold to hospitals and diagnostic laboratories in North America, Europe and parts of Asia. The company was co-founded by Daniel Levner and Yossi Pollak and has raised USD 71.00 mn in total, most recently in a Series D round on July 23, 2020, co-led by Clal Biotechnology and Koch Disruptive Technologies.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in